New Hope for Pediatric Migraine Care With AJOVY

Our guests today are participating on behalf of Teva Pharmaceuticals. Participants have been compensated for their time and appearance. This content is for informational purposes only and is not medical advice.

In this episode of Migraine Realities, pediatric and adult neurologist Dr. Jennifer McVige of DENT Neurologic Institute joins Lindsay Mang, a parent advocate, to talk about what pediatric migraine truly looks like and why early, informed care can make such a difference. They discuss how migraine often begins in childhood or adolescence and why careful listening to both children and their families plays a central role in diagnosis and long-term care. Dr. McVige also explains how pediatric migraine can present differently from adult migraine and how treatment decisions evolve as children grow.

Lindsay shares her family’s experience navigating migraine care for her son and what changed after starting AJOVY, a preventive treatment recently approved for episodic migraine in children and adolescents ages 6 to 17. The conversation reflects on how preventive treatment may help reduce migraine frequency and support day-to-day functioning, allowing kids to stay more fully engaged in their lives. This episode offers clear clinical perspective, real-world experience, and measured hope for families exploring evidence-based options in pediatric migraine care.